Opinion
Despite ongoing challenges, experts are optimistic about the future of MS therapy
To celebrate our 30th year in print, Neurology Reviews invited experts to look back on the trajectories of various neurology subspecialties. In...
News
Stroke management: A 30-year retrospective
Dr. Louis Caplan looks back on the successes and failures in stroke research and treatment.
News
Race, ethnicity, and socioeconomics are often barriers to migraine care
People of African descent and Latinx ethnicity tend to fare worse than other people of color and their White counterparts.
News
Ubrogepant safety and efficacy not affected by triptan therapy
The CGRP receptor antagonist shows promise, but hurdles set up by insurance companies limit its potential.
News
Adherence and discontinuation limit triptan outcomes
Low rates of triptan adherence are likely caused by disappointing efficacy and/or unpleasant side effects rather than economic considerations.
News
New sickle cell drugs give hope, but access remains a barrier
"SCD reduces lifespan by 30 years, and that's very hard to quantify," says Dr. Ifeyinwa Osunkwo.
News
Orthopedic ambulatory surgery centers beat inpatient services on cost
NATIONAL HARBOR, MD. – A study suggests that ambulatory surgery centers for orthopedic surgery deliver similar outcomes at a lower price than...
News
Strategy critical to surviving drug shortages
NATIONAL HARBOR, MD. – The impact of drug shortages transcends the inability to supply patients with first-line or optimal therapy. Education is...
News
Technology softens prior authorization pain points
NATIONAL HARBOR, MD. – Unclear drug pricing on prior authorizations creates a climate of frustration for clinicians and patients, but technology...
News
Migraine therapy efficacy leaves ambiguities
NATIONAL HARBOR, MD. – Selecting the ideal pharmacologic treatment for migraines remains a challenge because of hard-to-compare real-world...
News
Pharmacist-prescribed hormonal contraception safe, effective
In 2016, Oregon became the first state to grant pharmacists authority to prescribe hormonal contraception without requiring consultation.